BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26963048)

  • 1. Probenecid Sensitizes Neuroblastoma Cancer Stem Cells to Cisplatin.
    Campos-Arroyo D; Maldonado V; Bahena I; Quintanar V; Patiño N; Carlos Martinez-Lazcano J; Melendez-Zajgla J
    Cancer Invest; 2016; 34(3):155-66. PubMed ID: 26963048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2 inhibitor YHO-13351 sensitizes cancer stem/initiating-like side population cells to irinotecan.
    Shishido Y; Ueno S; Yamazaki R; Nagaoka M; Matsuzaki T
    Anticancer Res; 2013 Apr; 33(4):1379-86. PubMed ID: 23564776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrandrine enhances cytotoxicity of cisplatin in human drug-resistant esophageal squamous carcinoma cells by inhibition of multidrug resistance-associated protein 1.
    Wang TH; Wan JY; Gong X; Li HZ; Cheng Y
    Oncol Rep; 2012 Nov; 28(5):1681-6. PubMed ID: 22941407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells.
    Sampson KE; Brinker A; Pratt J; Venkatraman N; Xiao Y; Blasberg J; Steiner T; Bourner M; Thompson DC
    Drug Metab Dispos; 2015 Feb; 43(2):199-207. PubMed ID: 25388687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo.
    Hu J; Zhang X; Wang F; Wang X; Yang K; Xu M; To KK; Li Q; Fu L
    Oncotarget; 2015 Dec; 6(42):44643-59. PubMed ID: 26556876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter.
    Qiu JG; Zhang YJ; Li Y; Zhao JM; Zhang WJ; Jiang QW; Mei XL; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Shi Z
    Oncotarget; 2015 Jun; 6(17):15494-509. PubMed ID: 25915534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of expression and activity of multidrug resistance proteins MRP2 and MDR1 by estrogenic compounds in Caco-2 cells. Role in prevention of xenobiotic-induced cytotoxicity.
    Arias A; Rigalli JP; Villanueva SS; Ruiz ML; Luquita MG; Perdomo VG; Vore M; Catania VA; Mottino AD
    Toxicology; 2014 Jun; 320():46-55. PubMed ID: 24685904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sonic hedgehog-glioma associated oncogene homolog 1 signaling enhances drug resistance in CD44(+)/Musashi-1(+) gastric cancer stem cells.
    Xu M; Gong A; Yang H; George SK; Jiao Z; Huang H; Jiang X; Zhang Y
    Cancer Lett; 2015 Dec; 369(1):124-33. PubMed ID: 26276718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
    Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
    Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of different drug-resistant phenotypes by an autocatalytic multitarget multiribozyme directed against the transcripts of the ABC transporters MDR1/P-gp, MRP2, and BCRP.
    Kowalski P; Surowiak P; Lage H
    Mol Ther; 2005 Apr; 11(4):508-22. PubMed ID: 15771954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
    Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
    Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 ncRNA.
    Vella S; Penna I; Longo L; Pioggia G; Garbati P; Florio T; Rossi F; Pagano A
    Sci Rep; 2015 Dec; 5():18144. PubMed ID: 26674674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.
    Chau WK; Ip CK; Mak AS; Lai HC; Wong AS
    Oncogene; 2013 May; 32(22):2767-81. PubMed ID: 22797058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
    Xie ZY; Lv K; Xiong Y; Guo WH
    Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
    Pituch-Noworolska A; Zaremba M; Wieczorek A
    Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Afatinib enhances the efficacy of conventional chemotherapeutic agents by eradicating cancer stem-like cells.
    Wang XK; He JH; Xu JH; Ye S; Wang F; Zhang H; Huang ZC; To KK; Fu LW
    Cancer Res; 2014 Aug; 74(16):4431-45. PubMed ID: 24972892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia.
    To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW
    Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.